Type 1 cannabinoid receptor mapping with [18 F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Several lines of evidence imply early alterations in metabolic, dopaminergic and endocannabinoid neurotransmission in Huntington’s disease (HD). Using [18F]MK-9470 and small animal PET, we investigated cerebral changes in type 1 cannabinoid (CB1) receptor binding in the quinolinic acid (QA) rat model of HD in relation to glucose metabolism, dopamine D2 receptor availability and amphetamine-induced turning behaviour.
Twenty-one Wistar rats (11 QA and 10 shams) were investigated. Small animal PET acquisitions were conducted on a Focus 220 with approximately 18 MBq of [18F]MK-9470, [18F]FDG and [11C]raclopride. Relative glucose metabolism and parametric CB1 receptor and D2 binding images were anatomically standardized to Paxinos space and analysed voxel-wise using Statistical Parametric Mapping (SPM2).
In the QA model, [18F]MK-9470 uptake, glucose metabolism and D2 receptor binding were reduced in the ipsilateral caudate-putamen by 7, 35 and 77%, respectively (all p < 2.10−5), while an increase for these markers was observed on the contralateral side (>5%, all p < 7.10−4). [18F]MK-9470 binding was also increased in the cerebellum (p = 2.10−5), where it was inversely correlated to the number of ipsiversive turnings (p = 7.10−6), suggesting that CB1 receptor upregulation in the cerebellum is related to a better functional outcome. Additionally, glucose metabolism was relatively increased in the contralateral hippocampus, thalamus and sensorimotor cortex (p = 1.10−6).
These data point to in vivo changes in endocannabinoid transmission, specifically for CB1 receptors in the QA model, with involvement of the caudate-putamen, but also distant regions of the motor circuitry, including the cerebellum. These data also indicate the occurrence of functional plasticity on metabolism, D2 and CB1 neurotransmission in the contralateral hemisphere.
- Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
European Journal of Nuclear Medicine and Molecular Imaging
Volume 37, Issue 12 , pp 2354-2363
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Type 1 cannabinoid receptor
- Small animal PET
- Huntington’s disease
- Industry Sectors
- Author Affiliations
- 1. Division of Nuclear Medicine, KU Leuven and University Hospital Leuven, Leuven, Belgium
- 2. MoSAIC, Molecular Small Animal Imaging Center, KU Leuven, Leuven, Belgium
- 6. Division of Nuclear Medicine, University Hospital Gasthuisberg, Herestraat 49 bus 7003, 3000, Leuven, Belgium
- 3. Institute for Biomedical Research (IIBB-CSIC), IDIBAPS, Barcelona, Spain
- 4. Laboratory for Radiopharmacy, KU Leuven, Leuven, Belgium
- 5. Laboratory for Neurobiology and Gene Therapy, KU Leuven, Leuven, Belgium